FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say

Inspectors charged with safeguarding America’s drug supply say they are reeling from deep cuts at the Food and Drug Administration despite promises by the Trump administration to preserve the work of the agency’s investigative force.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.